1 min read.Updated: 17 Aug 2022, 03:25 PM ISTLivemint
Rare Enterprises-backed Concord Biotech has filed its DRHP with SEBI
Listen to this article
Late billionaire investor Rakesh Jhunjhunwala's firm Rare Enterprises-backed Concord Biotech has filed its draft red herring prospectus (DRHP) with capital markets regulator Securities Exchange Board of India (Sebi) to raise funds through an initial public offering (IPO).
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.